TMEM229A and non-small cell lung carcinoma: Conversely, TMEM229A overexpression can inhibit NSCLC cell proliferation, migration, and invasion while promoting E-cadherin overexpression and N-cadherin and matrix metalloproteinase 2 underexpression [8].